BRAF mutations: What are the treatment options?

Date 09 October 2016
Event ESMO 2016 Congress
Session New molecular challenges in CRC
Topics Anticancer agents
Gastrointestinal Cancers
Therapy
Biological Therapy
Presenter Fotios Loupakis
Authors F. Loupakis
  • Department Of Clinical And Experimental Oncology, Istituto Oncologico Veneto IOV IRCCS, 57100 - Livorno/IT